Pure Global

BECLOSP 40 MCG AEROSOL INHALATION, SOLUTION, 120 DOSES - Turkey License 95366aec2ae086eb259edccc3dbdf61d

Access comprehensive regulatory information for BECLOSP 40 MCG AEROSOL INHALATION, SOLUTION, 120 DOSES in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 95366aec2ae086eb259edccc3dbdf61d with license number 2023/89and contains active ingredient Beclomethasone dipropionate . The license is held by DEVA HOLDฤฐNG A.ลž..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
95366aec2ae086eb259edccc3dbdf61d
License Details
Turkey SFDA License: 95366aec2ae086eb259edccc3dbdf61d
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

BECLOSP 40 MCG AEROSOL INHALATION, SOLUTION, 120 DOSES
TR: BECLOSP 40 MCG AEROSOL ฤฐNHALASYONU, ร‡ร–ZELTฤฐ, 120 DOZ
Pharmaceutical Product

License Details

95366aec2ae086eb259edccc3dbdf61d

2023/89

8699525529879

RO3BA01

License Holder Information

Active Ingredient

Beclomethasone dipropionate

License Information

Mar 19, 2023